The Safety Profiles of Orlistat and Sibutramine: Results of Prescription‐Event Monitoring Studies in England

Michael Perrio, Lynda V. Wilton, Saad Shakir

Obesity · 2007 · 55 citations · 25 references

DOIFull text

Open access

Abstract

The PEM studies highlighted different adverse event profiles for orlistat and sibutramine that were consistent with their distinct pharmacological mechanisms and other published information.

References

25